Ausgabe 1/2021
Inhalt (13 Artikel)
Clinical Pharmacokinetics and Pharmacodynamics of Anti-Tubercular Drugs in Pregnancy
Jennifer R. Shiu, Alan Min, Tony K. L. Kiang
The Impact of Fasting on Major Metabolic Pathways of Macronutrients and Pharmacokinetics Steps of Drugs
Reza Karimi, Anita Cleven, Fawzy Elbarbry, Huy Hoang
Physiologically Based Pharmacokinetic Modeling Approach to Identify the Drug–Drug Interaction Mechanism of Nifedipine and a Proton Pump Inhibitor, Omeprazole
Maxime Le Merdy, Ming-Liang Tan, Dajun Sun, Zhanglin Ni, Sue-Chih Lee, Andrew Babiskin, Liang Zhao
Population Pharmacokinetics of Cariprazine and its Major Metabolites
Antonia Periclou, Luann Phillips, Parviz Ghahramani, Margit Kapás, Timothy Carrothers, Tatiana Khariton
Comparison of the Pharmacokinetics of RIPK1 Inhibitor GSK2982772 in Healthy Western and Japanese Subjects
Debra J. Tompson, Carwyn Davies, Nicola E. Scott, Edward P. Cannons, Michalis Kostapanos, Annette S. Gross, Marcy Powell, Hiroko Ino, Ryutaro Shimamura, Hirofumi Ogura, Takashi Nagakubo, Harue Igarashi, Atsushi Nakano
The Effect of Verapamil, a P-gp Inhibitor, on the Pharmacokinetics, Safety, and Tolerability of Omadacycline in Healthy Adults: A Phase I, Open-Label, Single-Sequence Study
Thomas L. Hunt, Evan Tzanis, Stephen Bai, Amy Manley, Surya Chitra, Paul C. McGovern
Differences in Intestinal Metabolism of Ginseng Between Normal and Immunosuppressed Rats
Jin-Hao Zhu, Jin-Di Xu, Shan-Shan Zhou, Xiao-Ya Zhang, Jing Zhou, Ming Kong, Qian Mao, He Zhu, Song-Lin Li
Impact of Human SULT1E1 Polymorphisms on the Sulfation of 17β-Estradiol, 4-Hydroxytamoxifen, and Diethylstilbestrol by SULT1E1 Allozymes
Amal A. El Daibani, Fatemah A. Alherz, Maryam S. Abunnaja, Ahsan F. Bairam, Mohammed I. Rasool, Katsuhisa Kurogi, Ming-Cheh Liu
Pharmacokinetics of the Urokinase Receptor-Derived Peptide UPARANT After Single and Multiple Doses Administration in Rats
Michele Ciccone, Daniele D’Alonzo, Alfonsina Mariarosaria Cangiano, Maria De Fenza, Vincenzo Pavone, Angelo Mancinelli
Rapalogues as hCES2A Inhibitors: In Vitro and In Silico Investigations
Cheng-Cheng Shi, Yun-Qing Song, Rong-Jing He, Xiao-Qing Guan, Li-Lin Song, Shi-Tong Chen, Meng-Ru Sun, Guang-Bo Ge, Li-Rong Zhang
Effect of Kidney Function and Dialysis on the Pharmacokinetics and Pharmacodynamics of Roxadustat, an Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor
Dorien Groenendaal-van de Meent, Virginie Kerbusch, Rudiger Kaspera, Begona Barroso-Fernandez, Piergiorgio Galletti, Gernot K. Klein, Martin den Adel
Comparison of Two Analytical Methods for Busulfan Therapeutic Drug Monitoring
Simona De Gregori, Carmine Tinelli, Federica Manzoni, Antonella Bartoli
Correction to: The Effect of Hydroxy Metabolites of Clarithromycin to the Pharmacokinetic Parameters, and Determination of Hydroxy Metabolites Ratio of Clarithromycin
Durısehvar Unal, Aysen Fenercıglu, Latıf Ozbay, Banu Ozkirim, Dılek Erol